RESEARCH MONOGRAPH · KDC-MN-110

Lion's Mane (Hericium erinaceus)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

65/100

NGF story is real in petri dish, less proven in humans. Hericenones and erinacines are the chemistry

Lion's Mane is the medicinal mushroom that built its modern reputation on the Kawagishi work in Japan showing the hericenones (from fruiting body) and erinacines (from mycelium) induce NGF expression in cultured cells. Thats a real finding, the hericenones and erinacine A in particular are reasonably well-characterized small molecules that cross the blood-brain barrier in animal models and drive measurable NGF transcription.

The Mori 2009 Japanese trial in mild cognitive impairment in older adults showed measurable improvements on the revised Hasegawa Dementia Scale at 3g/day of hericium powder over 16 weeks, with the signal regressing after washout. Thats one positive small trial. A handful of others have been done in mood, anxiety, and post-concussion symptom domains, with mixed results and small sample sizes. The Saitsu 2019 trial in subjective cognitive complaint adults showed some signal on cognitive function tests.

The marketing has run pretty far ahead of the literature, which is the typical story for medicinal mushrooms. Lions Mane became the "nootropic mushroom" in the supplement industry with a lot of confident neuroregeneration claims that the human trial base really doesn't support yet.

What we like: actual identified active compounds (hericenones C/D/E and erinacines A/B/C) with NGF-induction activity in cell-based assays. Reasonably plausible mechanism that could matter for nerve injury, neurodegeneration, or possibly mood and cognition. One properly-conducted MCI trial showing modest signal.

What we dont like is the dual problem of weak human trials and enormous variation in commercial product chemistry. Mycelium-on-grain products (the cheap end) often contain very little of the relevant erinacines. Fruiting body extracts vary in hericenone content. Beta-glucan content is sometimes what gets standardized but that's not the cognitive-active component. Quality is genuinely a coin flip with this category.

Sourcing: look for dual-extracted fruiting body material (hot water + alcohol) with documented hericenone content, not just beta-glucan percentages or polysaccharide totals. Real Mushrooms and Nammex are two suppliers with credible analytics. Avoid anything that's just "mycelium powder" without further characterization, the actual content of bioactive compounds is often very low.

Honestly we think Lion's Mane is intriguing but undertested, and the marketing currently exceeds the evidence by a wide margin. The NGF in vitro story is genuine, the human translation is much less established.

Evidence: 50
Mechanism: 65
Reliability: 55
Safety: 88
Sourcing: 55
Value: 65
Signal: 72
Staying power: 68

Plain-language summary Intrigue 65 / 100

Lion's mane mushroom (Hericium erinaceus) contains hericenones and erinacines that promote nerve growth factor (NGF) production. Used as a nootropic and being studied for cognitive decline. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Medicinal mushroom / NGF inducer

A medicinal mushroom containing hericenones and erinacines with documented NGF induction and modest cognitive enhancement in mild cognitive impairment.

Abstract

Hericium erinaceus (Lion's Mane mushroom) is a medicinal mushroom containing hericenones (in the fruiting body) and erinacines (in the mycelium), both classes of which induce nerve growth factor (NGF) expression in vitro and in vivo. NGF is critical for cholinergic neuron survival and function. A small randomized trial in Japanese subjects with mild cognitive impairment showed cognitive endpoint improvements with chronic Lion's Mane supplementation (3 grams over 16 weeks). Additional studies suggest peripheral nerve regeneration applications and modest anxiolytic effects. The compound is sold as both fruiting body extracts and mycelium-on-grain products; the latter contains erinacines but also significant residual grain (rice, oats) which has led to controversy about active constituent content. Reported research dose ranges in the literature span roughly 500 mg to 3 grams of the fruiting body extract.

Mechanism of action

NGF induction through hericenones (fruiting body) and erinacines (mycelium). Cholinergic neuron support.

Reported research dose ranges

Reported research dose ranges in the literature span roughly 500 mg to 3 grams of fruiting body extract.

References

Mori K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 2009.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-110

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Lion's Mane (Hericium erinaceus)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs